Is drug delivery the enemy of drug research?

Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-01-01-2003
Volume 15
Issue 1

Brussels report

The European drug industry's dilemma gets no easier - drugs must be discovered before they can be delivered. However, the pharmaceutical sector's reluctance to pay for delivery still threatens to deprive the industry of the revenue to do its research.

This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europesubscribe here now.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content